Speaker(s):
Teresa Baker, MD, FACOG, Outside Speaker, Texas Tech University - has nothing to disclose.
Moderator(s):
Dr. Keith Williams, MD, Staff member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Describe difference between phytocannabinoids and endocannabinoids
Describe potential role of endocannabinoids in human milk
Describe factors that may influence the level of endocannabinoids in human milk
To understand factors associated with frequent cannabis use in breastfeeding mothers
To describe the transfer of Δ9-THC and its metabolites into human milk at 20 min, 1, 2 and 4 hours after maternal inhalation of 0.1 g cannabis containing 23.18% of Δ9-THC
To discuss ethical issues regarding cannabis and breastfeeding
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Jay Bringman, MD, Sandra Culbertson, MD, Brittany Meyer, PA-C, Michelle Bafile, PA-C, Lindsay Payne, Stephanie Worhach, RN, Keith Williams, MD, and Orlando Valle, MD have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose: Michaelyn Notz, DO, Timothy Murphy, MD
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
- 1.00 AAPA Category I CME
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit

Facebook
X
LinkedIn
Forward